Early-Onset Cancer Surge: What Drives Rising Rates in Adults Under 50
Cancer was once considered predominantly a disease of aging, but a disturbing epidemiological shift is now forcing oncologists and preventive medicine…
Found 1710 results for "cancer"
Cancer was once considered predominantly a disease of aging, but a disturbing epidemiological shift is now forcing oncologists and preventive medicine…
Understanding why men and women respond differently to the same cancer therapies has long frustrated oncologists. A large-scale proteogenomic analysis now…
Ovarian cancer kills more women than any other gynecologic cancer precisely because it is almost always diagnosed late — when five-year survival drops below…
Cardio-oncology faces a persistent blind spot: by the time chemotherapy-induced heart damage becomes clinically apparent, meaningful cardiac function is…
Photodynamic therapy has long held promise for treating skin cancer without the collateral damage of systemic chemotherapy, but its Achilles' heel has been…
Uterine prolapse affects millions of women globally, yet the optimal surgical approach remains contested. A comprehensive evidence synthesis now positions the…
The possibility that a widely prescribed erectile dysfunction drug could meaningfully interfere with cancer spread reframes how oncologists and patients might…
For men whose prostate cancer has outrun hormone therapy, treatment options narrow sharply and survival odds remain grim. A newly identified molecular…
Colorectal cancer mortality is increasingly a problem for adults under 65 — a demographic once considered relatively protected — making the timing of this…
Brain cancer immunotherapy has long been assumed to succeed or fail based on T cell activity within tumors — a framework this research fundamentally…
A UC Berkeley team demonstrated that combining dichloroacetate (DCA), metformin, and a 10-fold reduced dose of Navitoclax (ABT-263) — branded as 'DMA'…
Treatment resistance in non-small cell lung cancer remains one of oncology's most stubborn problems, and mounting evidence points to the tumor's surrounding…
As oncology care grows more complex and multidisciplinary tumor boards (MTBs) face mounting resource pressures, the question of whether AI can meaningfully…
When a cancer spreads into the central nervous system, it typically signals one of medicine's most difficult clinical scenarios. For multiple myeloma patients…
The structural architecture of immune tissue — not just tumor biology — may hold untapped prognostic power in breast cancer. Most clinical attention focuses…
Brain cancer immunotherapy has long been dominated by a T cell-centric narrative — checkpoint inhibitors were assumed to work primarily by unleashing…
For individuals carrying Lynch syndrome mutations, colonoscopy surveillance is a cornerstone of cancer prevention — yet the biology of this hereditary…
When patients and their oncologists hold fundamentally different assumptions about the same therapy, clinical encounters break down — and that communication…
Triple-negative breast cancer remains among the most treatment-resistant malignancies precisely because it lacks the molecular handles — hormone receptors…
Understanding how cancers evolve, spread, and respond to treatment has long been constrained by the limitations of single imaging technologies — each offering…